Skip to content

Prospective study about preventive drainage tube placement at laparoscopic liver resection(Randomized Controlled Trial)

Prospective study about preventive drainage tube placement at laparoscopic liver resection(Randomized Controlled Trial) - Drainage tube study at laparoscopic liver resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029217
Enrollment
350
Registered
2017-09-20
Start date
2017-09-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver tumor

Interventions

control group(drainage tube placement group) Standards of treatment content 1)The type and number of drainage tube, the place of detention are not specified, but in principle the closed type drain

Sponsors

Osaka University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)A patient with liver tumor that is indicated for laparoscopic hepatectomy(except biliary reconstruction). 2)A patient who have obtained written consent from participants in this study. 3)PS:0-1(ECOG grade) 4)A Patient found to have the function of the main organs by clinical examination within 28 days before registration. 5)Child-Pugh classification:A or B

Exclusion criteria

Exclusion criteria: 1)A patient scheduled for other organ resection(excluding gallbladder) as combined resection. 2)A Patient who left bile drainage tube(C tube etc) during operation. 3)A patient with severe complications as follows. intestinal palsy, intestinal obstruction, interstitial pneumonia, pulmonary fibrosis, uncontrollable diabetes, heart failure, renal failure, liver failure, active ulcer of the gastrointestinal tract and active varicose veins, severe psychiatric disorders and depressive state. 4)A patient who is pregnant, has a possibility of pregnancy, is breastfeeding. 5)In addition, it is judged that the examination responsible doctor or the test sharing doctor is inappropriate as the subject of this examination.

Design outcomes

Primary

MeasureTime frame
The rate of incidence of adverse event correlated with liver resection(bile leakage, bleeding, thoracicoabdominal fluid, intra-abdominal abscess, wound infection:more than Grade2 of Clavien-Dindo classification)

Secondary

MeasureTime frame
other adverse event, postoperative hospital stay

Countries

Japan

Contacts

Public ContactTakehiro Noda

Graduate School of Medicine, Osaka University Gastroenterological Surgery

tnoda@gesurg.med.osaka-u.ac.jp06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026